- Home
- HDL vs SPRY Comparison
HDL vs SPRY Comparison
Compare HDL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HDL | SPRY |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 946.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | HDL | SPRY |
|---|---|---|
| Price | $17.00 | $10.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $31.25 |
| AVG Volume (30 Days) | 2.1K | ★ 1.9M |
| Earning Date | 11-26-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $820,865,000.00 | $142,772,000.00 |
| Revenue This Year | $11.19 | N/A |
| Revenue Next Year | $13.37 | $124.59 |
| P/E Ratio | $429.66 | ★ N/A |
| Revenue Growth | 8.02 | ★ 5459.66 |
| 52 Week Low | $16.30 | $6.66 |
| 52 Week High | $30.00 | $18.90 |
Technical Indicators
Market Signals| Indicator | HDL | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 58.05 |
| Support Level | $16.99 | $9.78 |
| Resistance Level | $17.49 | $10.71 |
| Average True Range (ATR) | 0.22 | 0.69 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 18.40 | 64.20 |
Price Performance
Historical ComparisonAbout HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.